Introduction
Epoxides 1 are useful building blocks in organic synthesis and a number of five-membered heterocycles can be prepared when they are treated with heterocumulenes. The reaction with carbon dioxide to furnish either cyclic-or poly-carbonates 2 and 3 has been extensively studied.
1,2,3 Other areas of interest include the formation of either cyclic dithiocarbonates 4 or trithiocarbonates 5, 4 and oxazolidinones 6 and 7 5 (Scheme 1).
Scheme 1. Synthesis of heterocycles from epoxides and heterocumulenes.
Oxazolidinones are an important class of heterocycles and have been found to be useful compounds in medicinal chemistry, 6 as well as being valuable synthetic intermediates.
7
The reaction of epoxides with isocyanates is one of the most useful and efficient methods for the synthesis of oxazolidinones (Scheme 1). A number of catalyst systems have been reported for this reaction, including ammonium salts, 8 lanthanide salts, 9 lithium halides, 10 magnesium halides, 11 tetraphenylantimony iodide 12 and trialkyltin halides. 13 Recently, our group has reported a number of highly efficient metal-based catalysts 8-10 for the formation of cyclic carbonates from epoxides and carbon dioxide (Figure 1 ). 14, 15, 16 Compounds 8 and 9 also exhibit excellent catalytic activity for the preparation of oxazolidinones.
5a,b Thus, 5 mol% of bimetallic aluminium(salen) complex 8 in the absence of a co-catalyst was found to be an active catalytic system for the synthesis of a range of mono-and di-substituted oxazolidinones. In the presence of tetrabutylammonium bromide (5 mol%), aluminium heterosorpionate complex 9 (5 mol%) was also shown to be an effective catalyst for the preparation of oxazolidinones. Six epoxides were reacted with six aromatic isocyanates to give 25 oxazolidinones, showing a broad substrate scope. More recently, our group has reported the synthesis of cyclic carbonates from epoxides and carbon dioxide using chromium(salphen) complex 10. 16 In this case, only 1.5 mol% of complex 10 was necessary to catalyse the synthesis of a range of cyclic carbonates, either from monosubstituted epoxides at room temperature and one bar carbon dioxide pressure, or from disubstituted epoxides at elevated temperature and pressure. In view of the high catalytic activity shown by complex 10, we decided to investigate its use in the related reaction between epoxides and isocyanates. Herein, we report the use of chromium(salphen) complex 10 as an efficient catalyst for the formation of oxazolidinones from epoxides and isocyanates.
Results and Discussion
Screening studies were carried out using styrene oxide 1a and phenyl isocyanate 11a in a 1:1 ratio under various reaction conditions (Scheme 2) and the results are shown in Table 1 . Initial experiments were undertaken using 1.5 mol% of both chromium(salphen) complex 10 and tetrabutylammonium bromide (TBAB) as a co-catalyst at 80 o C for 24 hour under solvent-free conditions (Table 1 , entry 1). However, the reaction mixture solidified after 30 minutes. This suggested that a solvent was necessary to increase the conversion to the oxazolidinone products. Toluene was selected based on literature precedent 5a,b and the reaction mixture was heated to 80 o C. After 24 hours, 75% conversion was obtained (Table 1 , entry 2). Control experiments proved to be very informative. In the absence of TBAB, chromium(salphen) complex 10 was able to catalyse the reaction itself and a 90% conversion was achieved, whereas in the absence of complex 10, only 7% conversion was observed (Table 1 , entries 3 and 4). Increasing the catalyst loading to 2.5 mol% was not beneficial while lowering the catalyst loading to 0.5 mol% resulted in low conversion (Table 1 , entries 5 and 6).
To further optimise the reaction conditions, a sample was taken after each hour and it was found that the reaction reached maximum conversion after 4 hours. It was therefore decided that 1.5 mol% of catalyst 10 and heating in toluene at 80 o C for 4 hours were the optimal reaction conditions for the synthesis of oxazolidinones from epoxides and isocyanates.
Scheme 2. Reaction of styrene oxide 1a with phenylisocyanate 11a. Having determined the optimal reaction conditions for the synthesis of oxazolidinones 6a and 7a from styrene oxide 1a and phenyl isocyanate 11a, a series of epoxides was used together with phenyl isocyanate 11a to give oxazolidinones 6b-g and 7b-g (Scheme 3). The results of this study are shown in Table  2 . Functionalised aliphatic epoxides (3-phenoxypropropylene oxide 1b and epichlorohydrin 1c) and unfunctionalised aliphatic epoxide 1d were all excellent substrates, giving high conversions and excellent regioselectivity to the 3,5-isomers 6b-d (Table 2 , entries 2-4). In contrast, glycidol 1e was found to be a poor substrate, giving a complex mixture from which no product could be isolated ( Table 2 , entry 5). When aromatic epoxides 1f and 1g, containing a halogen at the para-position were used as substrates, good conversions were obtained though with no regioselectivity (Table 2 , entries 6 and 7). To further expand the substrate scope, styrene oxide 1a and epichlorohydrin 1c were selected as representative aromatic and aliphatic epoxides respectively for the synthesis of oxazolidinones from various isocyanates (Scheme 4). Five substituted aromatic isocyanates 11b-f and two aliphatic isocyanates 11g and 11h were reacted with these epoxides and the results are summarised in Table 3 . It was found that aromatic isocyanates 11b,c gave good to excellent conversions after 4 hours. A 1:1 ratio of 3,4-and 3,5-regioisomers was observed when styrene oxide 1a was used, while with epichlorohydrin 1c, complete regioselectivity for the 3,5-isomer was achieved (Table 3 , entries 1-5 and 8-12). In comparison, no conversion was obtained when aliphatic isocyanates 11g,h were used (entries 6,7 and 13,14). With aromatic isocyanates that have halogen groups at the para-position, chromium(salphen) complex 10 was found to catalyse the formation of both oxazolidinones and isocyanurates (perhydro-1,3,5-triazine-2,4,6-triones) 12 ( Figure 2 ) ( Table 3, Isocyanurates have previously been prepared by the cyclotrimerisation of isocyanates catalysed by species including organotin 19 and organozinc compounds, 20 copper and nickel halides 21 and palladium, 22 magnesium 23 and iron complexes. The formation of isocyanurates 12a-c was much less important when the competing reaction was between epichlorohydrin 1c and isocyanates than when styrene oxide 1a was used. However, since the separation of oxazolidinones 6q-s from isocyanurates 12a-c proved difficult, the isolated yields of these oxazolidinones were less than satisfactory (Table 3 , entries [10] [11] [12] . The formation of isocyanurates as by-products from the reaction between epoxides and isocyanates has not previously been reported. A control experiment using 4-fluorophenyl isocyanate 11d in the presence of chromium complex 10 under the standard reaction conditions but in the absence of an epoxide also gave isocyanurate 12a, indicating that chromium complex 10 is a strong Lewis acid and capable of catalysing the cyclotrimerisation of isocyanates. In the absence of chromium complex 10, only the starting material 4-fluorophenyl isocyanate was recovered. When isocyanates that have an electrondonating substituent at the para-position such as 11b were used, the corresponding urea 13 was isolated rather than the isocyanurate. Table 3 . Synthesis of oxazolidinones 6,7h-u using complex 10.
[a]
Entry Epoxide Isocyanate Conv.
[b]
[a] Reactions were carried out using 1. The chemo-and regio-selectivities observed when using complex 10 as a catalyst can be explained by the catalytic cycles shown in Scheme 5. Complex 10 can act both as a Lewis acid and as a source of a good nucleophile (chloride). Substrates 1 and 11 possess three sites which are susceptible to nucleophilic attack: both ends of the epoxide and the central carbon atom of the isocyanate. They also possess two sites for Lewis acid activation: the epoxide oxygen and the isocyanate oxygen. For oxazolidinone formation, the chromium(salphen) species first acts as a Lewis acid, activating the epoxide towards ring-opening by chloride anion. The regioselectivites observed with epoxides 1a-g are consistent with ring-opening of the activated epoxide normally occurring at the less-hindered, unsubstituted position by an SN2 type mechanism, eventually giving the 3,5-isomer of the oxazolidinone. However, when R 1 is an aromatic group capable of stabilising a benzylic carbenium ion, then ring-opening of the epoxide at the more-hindered, substituted position ultimately leading to the 3,4-isomer of the oxazolidinone becomes competitive and little or no regioselectivity is observed. The chromium coordinated alkoxide then reacts with the isocyanate to form a carbamate and this ring closes to give oxazolidinone 6 or 7 with regeneration of catalyst 10. For isocyanurate formation, the isocyanate oxygen atom coordinates competitively to the metal centre, followed by the nucleophilic attack of the chloride anion to give a chromium complexed carbomoyl chloride complex A. Following this, the nucleophilic nitrogen can then react further with two molecules of isocyanates before ring-closing with elimination of chloride to form isocyanurates 12 and regenerate catalyst 10.
Conclusions
Chromium(salphen) complex 10 was found to catalyse the formation of oxazolidinones from epoxides and isocyanates in the absence of a co-catalyst. Compared to previously reported aluminium(salen) complexes, chromium(salphen) complex 10 appears to be more Lewis acidic. This allows the catalyst loading to be reduced to 1.5 mol% and the reaction time to be reduced to 4 hours. However, the enhanced Lewis acidity of complex 10 causes the reaction to take a different pathway with electron-deficient isocyanates, leading to the formation of isocyanurates 12 by a pathway that involves Lewis acid activation and subsequent trimerisation of the isocyanate rather than Lewis acid activation of the epoxide. These results illustrate that although a strongly Lewis acidic catalyst is desirable to activate the epoxide for the formation of oxazolidinones from epoxides and isocyanates, the optimal catalyst for the process is substrate dependent and requires the electronic properties of both substrates and catalyst to be matched.
Experimental Section
Catalyst 10 was prepared as previously reported. 16 All other compounds were commercially available and used as supplied. 1 H NMR and 13 C NMR were recorded in CDCl3 at 25 o C on a JEOL 400 spectrometer operating at 400 and 100 MHz, respectively. Melting points were determined using a Stuart SMP3 apparatus. Infrared spectra were recorded on a Bruker Vertex 70 instrument. were added to a solution of catalyst 10 (0.013 mmol) in toluene (0.5 mL). The resulting mixture was stirred at 80 o C for 4 hours.
After being allowed to cool to room temperature, toluene was removed under pressure to give the crude oxazolidinone products. The conversion of epoxide to oxazolidinone was determined by 1 H NMR spectroscopy of the crude mixture. The products were purified by flash chromatography to give compound 6/7 a-s. 3,5-Diphenyloxazolidin-2-one (6a): Obtained as a yellow solid after purification by flash chromatography using a solvent system of first hexane-EtOAc 
3-Phenyl-5-(4-chlorophenyl)-oxazolidin-2-one (6f):
Obtained as a pale yellow solid after purification by flash chromatography using a solvent system of CH2Cl2-hexane (4:1) (68 mg, 30% 3-Phenyl-5-(4-bromophenyl)-oxazolidin-2-one (6g): Obtained as a white solid after purification by flash chromatography using a solvent system of first hexane-EtOAc (7:1), then hexaneEtOAc (4:1), then hexane-EtOAc (3:1), (77 mg, 30% 1726.
3-Phenyl-4-(4-bromophenyl)-oxazolidin-2-one (7g):
Obtained as a yellow solid after purification by flash chromatography using a solvent system of first hexane-EtOAc 3-(4-Chlorophenyl)-4-phenyloxazolidin-2-one (7k): Obtained as a pale yellow solid in a mixture with 12b after purification by flash chromatography using a solvent system of hexane-EtOAc (9:1) (22 mg, 10% 
3-(4-Bromophenyl)-5-chloromethyloxazolidin-2-one (6s):
Obtained as a yellow solid after purification by flash chromatography using a solvent system of first hexane-EtOAc (3:1), then hexane-EtOAc (2:1) (92 mg, 36% 
